Pathogenesis of osteoporosis

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 1, 2003, Pages 15-24

  Raisz, Lawrence G ^a   Rodan, Gideon A ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR;

BONE FRAGILITY; BONE MASS; BONE REMODELING; BONE STRENGTH; CYTOKINE RELEASE; ESTROGEN DEFICIENCY; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

ANIMALIA; PRIMATES; RODENTIA;

EID: 0037300532     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00055-5     Document Type: Review

References (61)

1. Raisz LG. Pathogenesis of postmenopausal osteoporosis. Rev Endocr Metab Disord 2001;2:5-12.
2. Raisz L. Local and systemic factors in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd edition. San Diego: Academic Press; 2001. p, 19-24.
3. Rodan GA, Raisz LG, Bilezikian JP. Pathophysiology of osteoporosis. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. 2nd edition. San Diego: Academic Press; 2002. p. 1291-301.
4. Teegarden D, Lyle RM, Proulx WR, et al. Previous milk consumption is associated with greater bone density in young women. Am J Clin Nutr 1999;69:1014-7.
5. Heinonen A, Sievanen H, Kannus P, et al. High-impact exercise and bones of growing girls: a 9-month controlled trial. Osteoporos Int 2000;11:1010-7.
6. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
7. Falahiti-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553-60.
8. Khosla S, Melton LJ III, Atkinson EJ, et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86:3555-61.
9. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences of bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
10. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000;192:4-13.
11. Khosla S. The OPG/RANKL/RANK system. Endocrinology 2001;142:5050-5.
12. Fuller K, Murphy C, Kirstein B, et al. TNFalpha potentially activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002;143:1108-18.
13. Li X, Okada Y, Pilbeam CC, et al. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000;141:2054-61.
14. Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999;140:3552-61.
15. Miura M, Tanaka K, Komatsu Y, et al. A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation. Biochem Biophys Res Commun 2002;291:987-994.
16. Ensrud KE, Duong T, Cauley JA, et al. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Ann Intern Med 2000;132:345-53.
17. Lorenzo J. Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest 2000;106:749-52.
18. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2002;98:281-9.
19. Takayanagi H, Iizuka H, Juji T, et al. Involvement of receptor activator of nuclear factor [kappa]b ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000;43:259-69.
20. Onoe Y, Miyaura C, Ito M, et al. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 2000;15:541-9.
21. Choi Y, Woo KM, Ko SH, et al. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CB8(+) T cells. Eur J Immunol 2001;31:2179-88.
22. Abrahamsen B, Shalhoub V, Larson EK, et al. Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women. Bone 2000;26:137-45.
23. Pfeilschifter J, Koditz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90-119.
24. Lorenzo JA, Naprta A, Rao Y, et al. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 1998;139:3022-5.
25. Kawaguchi H, Pilbeam CC, Vargas SJ, et al. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 1995;96:539-48.
26. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001;86:2032-42.
27. Suda T, Miyaura C. Pathogenesis of bone loss due to estrogen deficiency. Osteoporos Int 1997;7:S43-46.
28. Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999;140:4367-70.
29. Hughes DE, Dai A, Tiffee JC, et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996;2:1132-6.
30. Wada S, Udagawa N, Nagata N, et al. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology 1996;137:1042-8.
31. Bendixen AC, Shevde NK, Dienger KM, et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci USA 2001;98:2443-8.
32. Horwood NJ, Elliott J, Martin TJ, et al. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001;166:4915-21.
33. Lorget F, Kamel S, Mentaverri R, et al. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 2000;268:899-903.
34. Cummings SR, Karpf DB, Harris F, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002;112:281-9.
35. Neer RM, Arnaud CD, Zanchetta JD, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
36. Lips P, Courpron P, Meunier PJ. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 1978;26:13-7.
37. Yudoh K, Matsuno H, Nakazawa F, et al. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res 2001;16:1453-64.
38. Kveiborg M, Kassem M, Langdahl B, et al. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech Ageing Dev 1999;106:261-71.
39. Seck T, Scheppach B, Scharla S, et al. Concentration of insulin-like growth factor (IGF)-I and -II iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 1998;83:2331-7.
40. Langlois JA, Rosen CJ, Visser M, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998;83:4257-62.
41. Boonen S, Mohan S, Dequeker J, et al. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP] and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 1999;14:2150-8.
42. Yamaguchi A, Toshihisa K, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs and Cbfal. Endocr Rev 2000;21:393-411.
43. Itoh K, Udagawa N, Katagiri T, et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001;142:3654-62.
44. Lecka-Czernik B, Gubrij I, Moerman EJ, et al. Inhibition of Osf2/Cbfal expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 1999;74:357-71.
45. Ducy P, Starbuck M, Priemel M, et al. A Cbfal-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999;13:1025-36.
46. Nakashima K, Shou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
47. Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002;70:11-9.
48. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513-23.
49. Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001;10:537-43.
50. Burguera B, Hofbauer LC, Thomas T, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001;142:3546-53.
51. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289:1501-4.
52. Jackson SM, Demer LL. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-El preosteoblasts. FEBS Lett 2000;471:119-24.
53. Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-I by osteoclasts. A mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002;277(24):21352-60.
54. Everts V, Delaisse JM, Korper W, et al. The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 2002;17:77-90.
55. Hauge EM, Qvesel D, Ericksen EF, et al. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001;16:1575-82.
56. Lanyon L, Skerry T. Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: a hypothesis. J Bone Miner Res 2001;16:1937-47.
57. Joldersma M, Klein-Nulend J, Oleksik AM, et al. Estrogen enhances mechanical stress-induced prostaglandin production by bone cells from elderly women. Am J Physiol Endocrinol Metab 2001;280:E436-42.
58. Van't Hof RJ, Ralston SH. Nitric oxide and bone, Immunology 2001;103:255-61.
59. Rodan GA. Bone mass homeostasis and bisphosphonate action. Bone 1997;20:1-4.
60. Raisz LG, Seeman E. Causes of age-related bone loss and bone fragility: an alternative view. J Bone Miner Res 2001;16:1948-52.
61. Wallace BA, Cumming RG. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 2000;67:10-8.